Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of therapies to address unmet medical needs and improve the lives of patients. The Companyâs commercial portfolio consist of three products: Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and for the treatment of nighttime sleep disturbances in Smith-Magenis syndrome (SMS) and PONVORY for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. In addition, it has a number of drugs and/or additional indications for current products in development, including Bysanti, Tradipitant, Imsidolimab, VTR-297, VQW-765, and others. Bysanti is the active metabolite of Fanapt.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļVNDA
āļāļ·āđāļāļāļĢāļīāļĐāļąāļVanda Pharmaceuticals Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļApr 12, 2006
āļāļĩāļāļĩāđāļPolymeropoulos (Mihael Hristos)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ368
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļApr 12
āļāļĩāđāļāļĒāļđāđSuite 300E
āđāļĄāļ·āļāļWASHINGTON
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ20037
āđāļāļĢāļĻāļąāļāļāđ12027343400
āđāļ§āđāļāđāļāļāđhttps://www.vandapharma.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļVNDA
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļApr 12, 2006
āļāļĩāļāļĩāđāļPolymeropoulos (Mihael Hristos)
iShares Neuroscience and Healthcare ETF
Invesco NASDAQ Future Gen 200 ETF
SPDR SSGA US Small Cap Low Volatility Index ETF
ALPS Medical Breakthroughs ETF
Federated Hermes MDT Small Cap Core ETF
ProShares Ultra Nasdaq Biotechnology
Franklin US Small Cap Multifactor Index ETF
Goldman Sachs ActiveBeta US Small Cap Equity ETF
JPMorgan Diversified Return U.S. Small Cap Equity ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
iShares Neuroscience and Healthcare ETF
āļŠāļąāļāļŠāđāļ§āļ0.49%
Invesco NASDAQ Future Gen 200 ETF
āļŠāļąāļāļŠāđāļ§āļ0.49%
SPDR SSGA US Small Cap Low Volatility Index ETF
āļŠāļąāļāļŠāđāļ§āļ0.12%
ALPS Medical Breakthroughs ETF
āļŠāļąāļāļŠāđāļ§āļ0.1%
Federated Hermes MDT Small Cap Core ETF
āļŠāļąāļāļŠāđāļ§āļ0.09%
iShares Micro-Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.05%
ProShares Ultra Nasdaq Biotechnology
āļŠāļąāļāļŠāđāļ§āļ0.04%
Franklin US Small Cap Multifactor Index ETF
āļŠāļąāļāļŠāđāļ§āļ0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.04%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.03%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ